NorthStar Healthcare Income, Inc. financial data

Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 08 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 431% % -20%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 185,712,103 shares 0%
Common Stock, Shares, Outstanding 185,712,103 shares 0%
Entity Public Float $0 USD
Common Stock, Value, Issued $1,857,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 185,712,103 shares 0%
Weighted Average Number of Shares Outstanding, Diluted 185,712,103 shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $211,470,000 USD 3.6%
General and Administrative Expense $11,965,000 USD -9.6%
Costs and Expenses $240,706,000 USD -18%
Income Tax Expense (Benefit) $82,000 USD 3.8%
Earnings Per Share, Basic 1 USD/shares
Earnings Per Share, Diluted 1 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $322,935,000 USD 299%
Intangible Assets, Net (Excluding Goodwill) $0 USD -100%
Assets $1,057,236,000 USD 1.9%
Liabilities $821,411,000 USD -10%
Retained Earnings (Accumulated Deficit) $1,480,719,000 USD 7.1%
Stockholders' Equity Attributable to Parent $238,199,000 USD 91%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $235,825,000 USD 91%
Liabilities and Equity $1,057,236,000 USD 1.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,262,000 USD 683%
Net Cash Provided by (Used in) Financing Activities $83,489,000 USD -444%
Net Cash Provided by (Used in) Investing Activities $85,670,000 USD 891%
Common Stock, Shares Authorized 400,000,000 shares 0%
Common Stock, Shares, Issued 185,712,103 shares 0%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $9,443,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $361,812,000 USD 315%
Interest Paid, Excluding Capitalized Interest, Operating Activities $7,956,000 USD -8.3%
Deferred Tax Assets, Valuation Allowance $17,355,000 USD 3.8%
Deferred Tax Assets, Gross $17,355,000 USD 3.8%
Depreciation $35,000,000 USD -6.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $97,993,000 USD 89%
Deferred Tax Assets, Operating Loss Carryforwards $16,489,000 USD 2.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $35,184,000 USD -6.8%
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Share-based Payment Arrangement, Expense $247,500 USD 9.7%
Interest Expense $51,531,000 USD 16%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%